Dyax: Detailed Company Information & Corporate Profile

Contact top employees from Dyax

Summary

Dyax, founded in 1989, operates as a biotechnology firm with 100–200 employees and an annual revenue between $25 million and $100 million. The company is headquartered in Burlington, Massachusetts, within the Greater Boston DMA, and was acquired by a larger organization. Its SIC code is 2836.

Key leaders include Greg Conley, Senior Scientist and Functional Group Head for Protein Sciences; Andrew Sternlicht, Vice President; Sharon Lefferts, Clinical Nurse Educator; Kelly Duncan, Regional Access Director; Jessica Kenyon, Manager of Quality Assurance; Carolyn Discafani, Director In Vivo Pharmacology; Mark Sawyer, Senior VP – Technical Operations; Jeff Cameron, Corporate Account Director; Shobhan, Sr Developer; Jane Lovascio, Regional Business Manager for the Rare Disease Business Unit; Bob Ladner, Chief Technical Officer; Lisa Sperry, Senior Director Quality; Toni Doherty, Manager of Administrative Services; Csaba Pazmany, Staff Scientist II.

Dyax Websitetakeda.com
Social Links
linkedInlinkedIn
Phone Number617-225-2500, 16172252501
Industries
Dyax Headquarters Address55 Network Drive, Burlington, MA, 01803 US
Company Size100-200 employees
SIC Code2836
NAICS Code325414 Biological Product (except Diagnostic) Manufacturing
DMA CodeGreater Boston
Founded1989
Estimated Annual Revenue$25M - 100M
Operating StatusAcquired
Updated:2026-09-27

Competitors

Name
Founded
Type
Employees
1994Public
Company
500 - 1.0K
1995Public
Company
5.0K - 10K
1991Public
Company
1.0K - 5.0K
2010Privately
Held
10-50

Estimated Website Traffic

The chart shows a growth in traffic to the takeda.com website. In September, traffic increased to 393060, compared to 355928 in the previous month. The highest traffic in 2026 was recorded in January, reaching 594187 visits.

Workforce Turnover

Length of Employment

arrow

Dyax's workforce includes employees across a wide range of tenure levels.

3% have been with the company for 8 to 10 years97% have been with the company for more than 11 years
Contact top employees from Dyax
Greg Conley
Greg ConleySenior Scientist/Functional Group Head Protein Sciences
Unlock contacts
Andrew Sternlicht
Andrew SternlichtVice President
Unlock contacts
Sharon Lefferts
Sharon LeffertsClinical Nurse Educator
Unlock contacts
Kelly Duncan
Kelly DuncanRegional Access Director
Unlock contacts
Jessica Kenyon
Jessica KenyonManager of Quality Assurance
Unlock contacts
Carolyn Discafani
Carolyn DiscafaniDirector In Vivo Pharmacology
Unlock contacts
Mark Sawyer
Mark SawyerSenior VP - Technical Operations
Unlock contacts
Jeff Cameron
Jeff CameronCorporate Account Director
Unlock contacts
Shobhan
ShobhanSr developer
Unlock contacts
Jane Lovascio
Jane LovascioRegional Business Manager-Rare Disease Business Unit
Unlock contacts
Bob Ladner
Bob LadnerChief Technical Officer
Unlock contacts
dyaa qamer
dyaa qamersocial service
Unlock contacts
Lisa Sperry
Lisa SperrySenior Director Quality
Unlock contacts
DRISCOLLS NYANDO
DRISCOLLS NYANDOLOG 4 TECHNICIAN
Unlock contacts
Toni Doherty
Toni DohertyManager, Administrative Services
Unlock contacts
Csaba Pazmany
Csaba PazmanyStaff Scientist II
Unlock contacts

Dyax Corporate Information: FAQ

Dyax operates in the Biotech industries. More details can be found on the official website: takeda.com.
Dyax has offices located in Burlington, US.
The headquarters of Dyax are located in Burlington, United States.
The current CEO of Dyax is Gustav A. Christensen
You can contact Dyax by phone at 617-225-2500, 16172252501.
Dyax currently employs 100-200 people.
Well-known competitors of Dyax include Exelixis, Exact Sciences, Incyte and Abzyme Therapeutics.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP